title: Aspirin and clopidogrel resistance: methodological challenges and opportunities.
abstract: Antiplatelet drug resistance is one of the urgent issues in current cardiovascular medicine. Many platelet function tests have been used to define responsiveness of patients with cardiovascular disease to aspirin and clopidogrel. In most studies, cut-off values of platelet function tests for defining responsiveness to antiplatelets were chosen arbitrarily. Different tests provided wide-ranging figures of the prevalence of aspirin and clopidogrel resistance, suggesting poor correlation between currently available platelet function tests. Measurement of platelet size seems to be a promising approach for monitoring antiplatelet drug therapy. This commentary highlights some limitations of studies on aspirin and clopidogrel resistance in patients undergoing coronary interventions.
authors.affiliation: Clinical Research Unit, Russell's Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, West Midlands, UK. a.gasparyan@gmail.com
authors.forename: Armen Yuri
authors.initials: AY
authors.lastname: Gasparyan
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077144:Clopidogrel; D004351:Drug Resistance; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin
references.citation: Eur Heart J. 2008 Dec;29(23):2877-85
references.pmid: 18826988
references.citation: Acta Haematol. 1999;101(3):140-4
references.pmid: 10352333
references.citation: Eur Heart J. 2007 Jul;28(14):1673-5
references.pmid: 17586540
references.citation: Blood Coagul Fibrinolysis. 2009 Dec;20(8):686-93
references.pmid: 19730245
references.citation: Eur Heart J. 2007 Jul;28(14):1702-8
references.pmid: 17569678
references.citation: Thorac Cardiovasc Surg. 2009 Aug;57(5):281-5
references.pmid: 19629890
references.citation: J Interv Cardiol. 2006 Dec;19(6):507-9
references.pmid: 17107365
references.citation: Stroke. 2006 Aug;37(8):2153-8
references.pmid: 16794200
references.citation: BMJ. 2002 Jan 12;324(7329):71-86
references.pmid: 11786451
references.citation: J Am Coll Cardiol. 2008 May 13;51(19):1829-43
references.pmid: 18466797
references.citation: J Transl Med. 2008 Aug 29;6:46
references.pmid: 18759978
references.citation: J Am Coll Cardiol. 2003 Mar 19;41(6):961-5
references.pmid: 12651041
references.citation: Vasc Health Risk Manag. 2009;5:965-72
references.pmid: 19997577
references.citation: Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108
references.pmid: 18448350
references.citation: Thromb Res. 2009 May;124(1):46-51
references.pmid: 19041120
references.citation: Am Heart J. 2007 Aug;154(2):221-31
references.pmid: 17643570
references.citation: J Thromb Haemost. 2007 Mar;5(3):507-11
references.pmid: 17319905
references.citation: Lancet. 2008 Apr 19;371(9621):1353-63
references.pmid: 18377975
references.citation: Thromb Res. 2010 May;125(5):406-12
references.pmid: 19786298